NF-1

01-C-0222 A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Principal Investigator: Dr. Brigitte Widemann

01-C-0091:A Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxelin Pediatric Patients with Refractory Solid Tumors Including Brain Tumors

Principal Investigator: Dr. Elizabeth Fox

04-C-0080:Phase II Trial of Pirfenidone in children, Adolescents, and Young Adults withNeurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Principal Investigator: Dr. Brigitte Widemann

06-C-0043: Phase II Trial of Neoadjuvant Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High-Grade Malignant Peripheral Nerve Sheath Tumor

Principal Investigator: Dr. Brigitte Widemann

Last Updated: :July 26, 2006

NCI Home Page|| NIH Home Page

© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute